skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: can I have your opinion on the growth potential for Fulcrum therapeutics? they recently announced positive results for their sickle cell disease trials
thanks
Read Answer Asked by Mary on December 13, 2021
Q: Hi,

I'm looking for 2 or 3 broad based ETFs that track the CDN TSX closely, and two or three ETFs that track the US broad market closely, for a 'couch potato' strategy.
Read Answer Asked by Graeme on December 13, 2021
Q: I have some ecn in my riff and need to get some cash available for my year end withdrawal and need to know if the dividend payment is in fact to be paid before year end to cover my government obligation so I will not have to sell other stocks to meet the cash requirement. Please advise.
Cheers Doug
Read Answer Asked by Doug on December 13, 2021
Q: Hi Peter, Ryan, and Team,

For my wife's 2022 TFSA contribution, and my contribution, and wishing to add to existing positions only, as well as noting that both sectors are low (according to Portfolio Analysis), would you be okay with adding the 6K to PBH for one account, and 6K to ENB for the other?

Thanks as always for your valued advice.
Read Answer Asked by Jerry on December 13, 2021
Q: When will you be updating your Portfolios on your website. It still is Octobers results.

Thanks


Sheldon
Read Answer Asked by Sheldon on December 13, 2021
Q: What are your top 10 non-tech growth stocks in the US that you see currently see as attractive long term? Thanks!
Read Answer Asked by Keith on December 13, 2021
Q: Hi everybody,
I know you don’t trust much analysts’ price target, but I’m still trying to get a picture for NFI.

Your Market Data shows recommandations from only 3 analysts 1Buy/1Hold/1Sell. TipRanks have 7 (4B,2H,1S), Yahoo Finance shows 8 analysts (6 Buy in November), BMO Investorline gives at least 6 recent price targets (mostly cuts). This is a bit frustrating… How often are the Market Data recommandations updated ? Can we rely on up to date Key Ratios?

Thanks.
Read Answer Asked by Denise on December 13, 2021
Q: Could you please rank in order as what you see as having the best long term growth potential? Or any names in the same field that you believe are even better. I’m pondering the companies that will benefit as a result of the report released today by the Canada Energy Regulator.
Thanks
Read Answer Asked by Curtis on December 13, 2021
Q: Hello 5i,

Fresh off a short attack on NVEI the US government has acknowledged they are looking into short-selling. It will be the usual debacle that accomplishes nothing.

Unethical short-selling while launching documents to the general public will only stop when disgruntled investors take matters into their own hand and remove upper management staff in organizations such as Spruce Point Management. Their philosophy is to repeat the NVEI and LSPD short-selling fiasco as a strategy to make huge profits.

It is truly unfortunate that human greed exceeds logical life decisions, It is amazing how many push this limit when it comes to money.

I'll be chilling in Cuba with a few drinks next week. Hopefully Ben Axler sits beside me. Now THAT would present an interesting life decision.

Cheers,
Read Answer Asked by Jerry on December 13, 2021
Q: Hello 5i team,
AEM has been on a steady decline since Oct of last year (~70%). Is this around the same time as news came of the merger with Kirkland?

I was thinking of entering into the gold/mineral space since I have no exposure. I looked at the slides for the merger, and paints a rosy picture (synergies, dividend growth, etc...). The markets do not seem to like this merger very much based on the price.

Is there anything you know of that would cause this drop aside from markets in general being weary of company mergers?

Thank You,
Andrew
Read Answer Asked by Andrew on December 13, 2021
Q: Hi Team,
What's your current views of MED and SWKS? I have been underwater pretty much on both these I bought them. Should I continue to hold or is there other stocks I should be replacing these with instead that stand out as screaming buys as of today? I particularly don't understand the weakness of SWKS. From what I can see it trades much cheaper valuation than most chips stocks, has good growth, has a partnership with Apple (which I know some view as a negative), is in the 5G business as well which should be a highly growing sector. The lack of interest is a bit confusing. Would it be a takeover target? You would think if chips are so hard to come buy perhaps apple would just buy them with their pocket change one day to bolster their supply chain? Thoughts? Thanks

Shane.
Read Answer Asked by Shane on December 13, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!